Consultant Proposes FDA/Industry Joint Panel In Place Of NDI Guidance
This article was originally published in The Tan Sheet
Executive Summary
FDA should scrap its new dietary ingredient notification guidance in favor of an FDA/industry joint panel that would create safety proposals regarding new ingredients, a consultant says.
You may also be interested in...
People In Brief
ChromaDex shakes up management; Perrigo adds corporate responsibility head; Office of Dietary Supplements adds 2 scientists; Oragenics adds adviser; Kidd joins Doctor's Best; Life Extension promotes Bristol-Myers vet; food safety experts support FDA’s Taylor.
People In Brief
ChromaDex shakes up management; Perrigo adds corporate responsibility head; Office of Dietary Supplements adds 2 scientists; Oragenics adds adviser; Kidd joins Doctor's Best; Life Extension promotes Bristol-Myers vet; food safety experts support FDA’s Taylor.
NDI Guidance Sparks Questions Even From Firms Ready To Comply
FDA’s new dietary ingredient notification draft guidance draws questions even from firms that expect compliance will not require drastic changes in their processes.